Randomized, double-blind, placebo-controlled trial of ISC 17536, an oral inhibitor of transient receptor potential ankyrin 1, in patients with painful diabetic peripheral neuropathy: impact of preserved small nerve fiber function
- DOI
- 10.1097/j.pain.0000000000002470
- Published
- 2021-09-02
- Container
- Pain
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1097/j.pain.0000000000002470,
title = {Randomized, double-blind, placebo-controlled trial of ISC 17536, an oral inhibitor of transient receptor potential ankyrin 1, in patients with painful diabetic peripheral neuropathy: impact of preserved small nerve fiber function},
author = {Sunil M. Jain and Ramanathan Balamurugan and Monika Tandon and Neelufar Mozaffarian and Girish Gudi and Yacine Salhi and Robert Holland and Roy Freeman and Ralf Baron},
year = {2021},
journal = {Pain},
doi = {10.1097/j.pain.0000000000002470},
url = {https://doi.org/10.1097/j.pain.0000000000002470}
}RIS
TY - JOUR TI - Randomized, double-blind, placebo-controlled trial of ISC 17536, an oral inhibitor of transient receptor potential ankyrin 1, in patients with painful diabetic peripheral neuropathy: impact of preserved small nerve fiber function AU - Sunil M. Jain AU - Ramanathan Balamurugan AU - Monika Tandon AU - Neelufar Mozaffarian AU - Girish Gudi AU - Yacine Salhi AU - Robert Holland AU - Roy Freeman AU - Ralf Baron PY - 2021 JO - Pain DO - 10.1097/j.pain.0000000000002470 UR - https://doi.org/10.1097/j.pain.0000000000002470 ER -
APA
Jain, S. M., Balamurugan, R., Tandon, M., Mozaffarian, N., Gudi, G., Salhi, Y., Holland, R., Freeman, R., & Baron, R. (2021). Randomized, double-blind, placebo-controlled trial of ISC 17536, an oral inhibitor of transient receptor potential ankyrin 1, in patients with painful diabetic peripheral neuropathy: impact of preserved small nerve fiber function. Pain. https://doi.org/10.1097/j.pain.0000000000002470
Source records
- crossref · retrieved 2026-09-26T21:31:47.225Z